- •Pediatric Retina
- •Preface
- •1: Development of the Retina
- •1.1 To suppose that the eye . . . could have been formed by natural selection, seems, I freely confess, absurd . . .1
- •1.2 Good order is the foundation of all things2
- •1.3 All that you touch you Change. All that Change Changes you3
- •1.4 Men are born with two eyes, but only one tongue, in order that they should see twice as much as they say4
- •1.7 More than Meets the Optic Vesicle6
- •1.9 Focusing on the Fovea: A Marvel of Development
- •1.10 Nature and Books belong to the eyes that see them7
- •References
- •2: Anatomy and Physiology of the Retina
- •2.1 Introduction
- •2.2 Anatomy of the Retina
- •2.2.2 Cellular Organization of the Retina
- •2.2.2.1 Retinal Pigment Epithelium
- •2.2.2.2 Photoreceptors
- •2.2.2.3 Interneuron Cells
- •2.2.2.4 Ganglion Cells
- •2.2.2.5 Glial Cells
- •2.2.3.1 Bruch’s Membrane
- •2.2.3.2 Retinal Pigment Epithelium
- •2.2.3.3 Photoreceptor Layer
- •2.2.3.4 External Limiting Membrane
- •2.2.3.5 Outer Nuclear Layer
- •2.2.3.6 Outer Plexiform Layer
- •2.2.3.7 Inner Nuclear Layer
- •2.2.3.8 Inner Plexiform Layer
- •2.2.3.9 Ganglion Cell Layer
- •2.2.3.10 Nerve Fiber Layer
- •2.2.5 Blood Supply of the Retina
- •2.2.5.1 Choroidal Circulation
- •2.2.5.2 Hyaloid Circulation
- •2.2.5.3 Retinal Circulation
- •2.2.5.5 Regulation of Blood Flow to the Retina
- •2.2.6 Optic Nerve
- •2.2.6.1 Physiology and Development
- •2.3 Physiology of the Retina
- •2.3.1 The Retinal Pigment Epithelium
- •2.3.3 Image-Forming Visual System
- •2.3.3.1 Detection of Photons by Visual Pigment in the Photoreceptor Cell
- •2.3.3.2 Light Activation of the Photopigment
- •2.3.4 Nonimage-Forming Visual System
- •2.3.5 Targets of Retinal Projections
- •2.4 Retinal Development
- •2.4.2 Foveal Development
- •References
- •3.1 Full-Field ERG
- •3.1.1.1 Rod Response
- •3.1.1.2 Standard Combined Response
- •3.1.1.3 Oscillatory Potentials
- •3.1.1.4 Single-Flash Cone Response
- •3.1.1.5 Light-Adapted Flicker Response
- •3.1.2 Repeat Variability
- •3.1.4 Clinical Uses of the Full-Field ERG
- •3.1.4.2 Stationary Night Blindness
- •3.1.4.3 Enhanced S-Cone Syndrome
- •3.1.4.4 Leber Congenital Amaurosis
- •3.2 Focal and Multifocal ERG
- •References
- •4: Retinopathy of Prematurity (ROP)
- •4.1 Introduction
- •4.2 History
- •4.3 Classification
- •4.4 Incidence
- •4.5 Natural History and Prognosis
- •Disease with Little or No Risk
- •Disease with Moderate Risk
- •Disease with High Risk
- •4.6 Pathogenesis
- •4.7 Screening
- •4.8 Management
- •4.9 Prevention
- •4.10 Interdiction
- •4.11 Corrective Therapy
- •4.12 Mitigation
- •4.13 Medicolegal Considerations
- •4.14 Conclusion
- •References
- •5: Optic Nerve Malformations
- •5.1 Optic Nerve Hypoplasia
- •5.1.1 Overview/Clinical Significance
- •5.1.2 Classification
- •5.1.3 Genetics
- •5.1.4 Pathophysiology
- •5.1.5 Natural History
- •5.1.6 Diagnosis
- •5.1.7 Treatment
- •5.2 Morning Glory Disc Anomaly
- •5.2.1 Overview/Clinical Significance
- •5.2.2 Classification
- •5.2.3 Genetics
- •5.2.4 Pathophysiology
- •5.2.5 Natural History
- •5.2.6 Diagnosis
- •5.2.7 Treatment
- •5.2.8 Associations and Complications
- •5.3 Optic Nerve Head Pits
- •5.3.1 Introduction
- •5.3.2 Overview with Clinical Significance
- •5.3.3 Classification
- •5.3.4 Genetics
- •5.3.5 Pathophysiology
- •5.3.6 Incidence
- •5.3.8 Diagnosis and Diagnostic Aids
- •5.3.9 Treatment
- •5.3.10 Complications and Associations
- •5.4 Optic Disc Coloboma
- •5.4.1 Introduction
- •5.4.2 Genetics
- •5.4.3 Pathophysiology
- •5.4.4 Natural History and Prognosis
- •5.4.5 Diagnosis and Diagnostic Aids
- •5.4.6 Treatment
- •5.5 Optic Nerve Tumor
- •5.5.1 Glioma
- •5.5.1.1 Introduction
- •5.5.2 Overview with Clinical Significance
- •5.5.2.1 Optic Nerve Glioma
- •5.5.2.2 Optic Chiasmal Glioma
- •5.5.3 Pathophysiology
- •5.5.4 Incidence
- •5.5.6 Diagnosis
- •5.5.7 Treatment
- •5.5.8 Social and Family Impact
- •5.6.1 Introduction
- •5.6.3 Pathophysiology
- •5.6.4 Incidence
- •5.6.5 Diagnosis and Diagnostic Aids
- •5.6.6 Treatment
- •5.7 Melanocytoma
- •5.7.1 Introduction
- •5.7.2 Pathophysiology
- •5.7.3 Natural History and Prognosis
- •5.7.4 Diagnosis and Diagnostic Aids
- •5.7.5 Treatment
- •5.8 Metastatic Tumors: Leukemia
- •5.8.1 Introduction
- •5.8.2 Pathophysiology
- •5.8.3 Natural History and Prognosis
- •5.8.4 Treatment
- •5.8.4.1 Other Elevated Disc Anomalies
- •5.9 Drusen
- •5.9.1 Introduction
- •5.9.2 Pathophysiology
- •5.9.3 Natural History and Prognosis
- •5.9.4 Diagnosis and Diagnostic Aids
- •5.10 Hyperopia
- •5.11 Persistence of the Hyaloid System
- •5.12 Tilted Disc
- •5.12.1 Introduction
- •5.12.2 Historical Context
- •5.12.3 Overview with Clinical Significance
- •5.12.4 Genetics
- •5.12.5 Pathophysiology
- •5.12.6 Incidence
- •5.13 Myelinated Nerve Fibers
- •5.13.1 Introduction
- •5.13.2 Genetics
- •5.13.3 Pathophysiology
- •5.13.4 Incidence
- •References
- •6.1.1 Albinism
- •6.1.1.1 Disorders Specific to Melanosomes
- •Hermansky–Pudlak Syndrome
- •Chediak–Higashi Syndrome
- •Diagnosis and Treatment
- •6.1.2 Gyrate Atrophy
- •6.1.3 Cystinosis
- •6.1.3.1 Primary Hyperoxaluria
- •6.2.1 The Gangliosidoses
- •6.2.2 GM1 Gangliosidosis
- •6.2.3 GM2 Gangliosidosis
- •6.2.3.1 Tay–Sachs Disease
- •6.2.4 Sandhoff Disease
- •6.2.5 Niemann–Pick Disease
- •6.2.7 Type C Niemann–Pick Disease
- •6.2.8 Fabry Disease
- •6.2.9 Farber Lipogranulomatosis
- •6.2.10 The Mucopolysaccharidoses
- •6.2.10.1.1 MPS I H: Hurler Syndrome
- •6.2.10.1.2 MPS I S: Scheie Syndrome
- •6.2.10.1.3 MPS I H/S: Hurler–Scheie Syndrome
- •6.2.10.2 MPS II: Hunter Syndrome
- •6.2.10.3 MPS III: Sanfilippo Syndrome
- •6.2.10.4 MPS IV: Morquio Syndrome
- •6.2.10.5 MPS VI: Maroteaux–Lamy Syndrome
- •6.2.10.6 MPS VII: Sly Syndrome
- •6.3 Disorders of Glycoprotein
- •6.3.1 Sialidosis
- •6.4 Disorders of Peroxisomes
- •6.4.1 Refsum Disease
- •References
- •7: Phacomatoses
- •7.1 Introduction
- •7.2 Neurofibromatosis
- •7.2.1 Neurofibromatosis Type 1
- •7.2.1.1 Introduction
- •7.2.1.2 Historical Context
- •7.2.1.3 Overview with Clinical Significance
- •7.2.1.4 Genetics
- •7.2.1.5 Natural History and Prognosis
- •7.2.1.6 Signs and Symptoms
- •7.2.2 Ocular Manifestations
- •7.2.2.1 Lisch Nodules
- •7.2.2.2 Optic Pathway Glioma
- •7.2.2.3 Neurofibroma of the Eyelid and Orbit
- •7.2.3 Systemic Manifestations
- •7.2.3.1 Café-au-lait Spot
- •7.2.3.2 Neurofibroma
- •7.2.3.3 CNS Abnormality
- •Diagnosis and Diagnostic Aids
- •Treatment
- •Social and Family Impact
- •7.2.4 Neurofibromatosis Type 2 (NF2)
- •7.2.4.1 Introduction
- •7.2.4.2 Historical Context
- •7.2.4.3 Overview with Clinical Significance
- •7.2.4.4 Classification
- •7.2.4.5 Genetics
- •7.2.4.6 Incidence
- •7.2.4.7 Natural History and Prognosis
- •7.2.4.8 Signs and Symptoms
- •Ocular Findings
- •Systemic Findings
- •Vestibular Schwannoma
- •Diagnosis and Diagnostic Aids
- •Treatment
- •Complications and Associations
- •Social and Family Impact
- •7.3 Von Hippel–Lindau Disease
- •7.3.1 Introduction
- •7.3.2 Historical Context
- •7.3.3 Overview with Clinical Significance
- •7.3.4 Classification
- •7.3.5 Genetics
- •7.3.6 Pathophysiology
- •7.3.7 Incidence
- •7.3.8 Natural History and Prognosis
- •7.3.9 Signs and Symptoms
- •7.3.9.1 Ocular Manifestations
- •Retinal Capillary Hemangioma
- •7.3.9.2 Systemic Manifestations
- •CNS Hemangioma
- •Renal Cell Carcinoma
- •Pheochromocytoma
- •Pancreatic Cystadenoma and Islet Cell Tumors
- •Epididymis Cystadenoma
- •7.3.10 Diagnosis and Diagnostic Aids
- •7.3.10.1 Coats’ Disease
- •7.3.10.2 Racemose Hemangioma
- •7.3.10.3 Retinal Cavernous Hemangioma
- •7.3.10.4 Retinal Macroaneurysm
- •7.3.10.5 Vasoproliferative Tumor
- •7.3.11 Fluorescein Angiography
- •7.3.12 Indocyanine Green Angiography
- •7.3.13 Ultrasonography
- •7.3.14 Magnetic Resonance Imaging
- •7.3.16 Treatment
- •7.3.17 Observation
- •7.3.18 Laser Photocoagulation
- •7.3.19 Cryotherapy
- •7.3.21 Plaque Radiotherapy
- •7.3.22 Proton Beam Radiotherapy
- •7.3.24 Enucleation
- •7.3.25 Social and Family Impact
- •7.4 Tuberous Sclerosis Complex
- •7.4.1 Introduction
- •7.4.2 Historical Context
- •7.4.3 Overview with Clinical Significance
- •7.4.4 Classification
- •7.4.5 Genetics
- •7.4.6 Incidence
- •7.4.7 Natural History and Prognosis
- •7.4.8 Signs and Symptoms
- •7.4.8.1 Ocular Findings
- •Retinal Astrocytic Hamartoma
- •7.4.8.2 Systemic Findings
- •Dermatologic Manifestations
- •Neurologic Manifestations
- •Visceral Manifestations
- •Diagnosis and Diagnostic Aids
- •Treatment
- •Social and Family Impact
- •7.5 Sturge-Weber Syndrome
- •7.5.1 Introduction
- •7.5.2 Historical Context
- •7.5.3 Overview with Clinical Significance
- •7.5.4 Incidence
- •7.5.5 Genetics
- •7.5.6 Pathophysiology
- •7.5.7 Natural History and Prognosis
- •7.5.8 Signs and Symptoms
- •7.5.8.1 Diffuse Choroidal Hemangioma
- •7.5.8.2 Glaucoma
- •7.5.8.3 Nevus Flammeus
- •7.5.8.4 Leptomeningeal Hemangiomatosis
- •7.5.8.5 Diagnosis and Diagnostic Aids
- •7.5.8.6 Treatment
- •7.5.8.7 Social and Family Impact
- •7.6 Wyburn-Mason Syndrome
- •7.6.1 Introduction
- •7.6.2 Historical Context
- •7.6.3 Overview with Clinical Significance
- •7.6.4 Classification
- •7.6.5 Genetics
- •7.6.6 Pathophysiology
- •7.6.7 Natural History and Prognosis
- •7.6.8 Signs and Symptoms
- •7.6.8.1 Ocular Findings
- •Retinal Arteriovenous Malformation
- •Diagnosis and Diagnostic Aids
- •Treatment
- •7.6.9 Ataxia Telangiectasia
- •7.6.9.1 Introduction
- •7.6.9.2 Historical Context
- •7.6.9.3 Overview with Clinical Significance
- •7.6.9.4 Classification
- •7.6.9.5 Genetics
- •7.6.9.6 Incidence
- •7.6.9.7 Natural History and Prognosis
- •7.6.9.8 Signs and Symptoms
- •7.6.9.9 Diagnosis and Diagnostic Aids
- •7.6.9.10 Treatment
- •7.6.9.11 Social and Family Impact
- •7.7 Retinal Caverous Hemangioma
- •7.7.1 Introduction
- •7.7.2 Historical Context
- •7.7.3 Overview with Clinical Significance
- •7.7.4 Genetics
- •7.7.5 Incidence
- •7.7.6 Natural History and Prognosis
- •7.7.7 Signs and Symptoms
- •7.7.7.1 Ocular Findings
- •7.7.7.2 Systemic Findings
- •Cutaneous Lesions
- •Diagnosis and Diagnostic Aids
- •Treatment
- •References
- •8.1 Introduction
- •8.2 Embryology
- •8.3 Clinical Findings
- •8.3.1 Primary anomalies
- •8.3.2 Secondary findings
- •8.3.3 Differential Diagnosis
- •8.3.3.1 Ancillary Tests
- •8.3.3.2 Prognosis
- •8.3.3.3 Treatment
- •8.4 Practical Surgical Issues
- •8.4.1 The Posterior Surgery
- •References
- •9.1 Introduction
- •9.2 Retinoblastoma Presentation SOP
- •9.2.1 Objective
- •9.2.2 Applicability
- •9.2.3 Scope
- •9.2.4 Clinical Significance
- •9.2.5 Procedures
- •9.2.6 Consequences
- •9.2.7 Related SOPs
- •9.3.1 Objectives
- •9.3.2 Applicability
- •9.3.3 Scope
- •9.3.4 Clinical Significance
- •9.3.5 Procedures
- •9.3.6 Consequences
- •9.3.7 Related SOPs
- •9.4 Genetics of Retinoblastoma SOP
- •9.4.1 Objective
- •9.4.2 Applicability
- •9.4.3 Scope
- •9.4.4 Clinical Significance
- •9.4.5 Procedure
- •9.4.6 Consequences
- •9.4.7 Related SOPs
- •9.5 Screening of Relatives SOP
- •9.5.1 Objective
- •9.5.2 Applicability
- •9.5.3 Scope
- •9.5.4 Clinical Significance
- •9.5.5 Procedure
- •9.5.6 Consequences
- •9.5.7 Related SOPs
- •9.6 Treatment SOP
- •9.7 Enucleation Indications SOP
- •9.7.1 Objective
- •9.7.2 Applicability
- •9.7.3 Scope
- •9.7.4 Clinical Significance
- •9.7.5 Procedure
- •9.7.6 Consequences
- •9.7.7 Related SOPs
- •9.8 Enucleation Technique SOP
- •9.8.1 Objectives
- •9.8.2 Applicability
- •9.8.3 Scope
- •9.8.4 Clinical Significance
- •9.8.5 Procedure
- •9.8.6 Consequences
- •9.8.7 Related SOPs
- •9.9.1 Objectives
- •9.9.2 Applicability
- •9.9.3 Scope
- •9.9.4 Clinical Significance
- •9.9.5 Procedure
- •9.9.6 Consequences
- •9.9.7 Related SOPs
- •9.10 Histopathology Analysis SOP
- •9.10.1 Objectives
- •9.10.2 Applicability
- •9.10.3 Scope
- •9.10.4 Clinical Significance
- •9.10.5 Procedure
- •9.10.6 Consequences
- •9.10.7 Related SOPs
- •9.11 Cryotherapy SOP
- •9.11.1 Objectives
- •9.11.2 Applicability
- •9.11.3 Scope
- •9.11.4 Clinical Significance
- •9.11.5 Procedure
- •9.11.6 Consequences
- •9.11.7 Related SOPs
- •9.12 Laser Therapy SOP
- •9.12.1 Objective
- •9.12.2 Applicability
- •9.12.3 Scope
- •9.12.4 Clinical Significance
- •9.12.5 Procedure
- •9.12.6 Consequences
- •9.12.7 Related SOPs
- •9.13 Local Chemotherapy SOP
- •9.13.1 Objectives
- •9.13.2 Applicability
- •9.13.3 Scope
- •9.13.4 Clinical Significance
- •9.13.5 Procedure
- •9.13.6 Consequences
- •9.13.7 Related SOPs
- •9.14 Systemic Chemotherapy SOP
- •9.14.1 Objectives
- •9.14.2 Applicability
- •9.14.3 Scope
- •9.14.4 Clinical Significance
- •9.14.5 Procedure
- •9.14.6 Consequences
- •9.14.7 Related SOPs
- •9.15 Radiation SOP
- •9.15.1 Objective
- •9.15.2 Applicability
- •9.15.3 Scope
- •9.15.4 Clinical Significance
- •9.15.5 Procedure
- •9.15.6 Consequences
- •9.15.7 Related SOPs
- •9.16.1 Objective
- •9.16.2 Applicability
- •9.16.3 Scope
- •9.16.4 Clinical Significance
- •9.16.5 Procedure
- •9.16.6 Consequences
- •9.16.7 Related SOPs
- •9.17 Follow-Up SOP
- •9.17.1 Objective
- •9.17.2 Applicability
- •9.17.3 Scope
- •9.17.4 Clinical Significance
- •9.17.5 Procedure
- •9.17.6 Consequences
- •9.17.7 Related SOPs
- •References
- •10: Coats’ Disease
- •10.1 Overview
- •10.3 Clinical Aspects
- •10.3.1 Demographics
- •10.3.2 Ocular Findings
- •10.4 Pathology and Pathophysiology
- •10.5 Genetics
- •10.6 Natural History
- •10.8 Management
- •10.9 Systemic Associations
- •10.10 Social and Family Impact
- •10.11 Future Treatment
- •References
- •11.1.1 Stargardt Macular Dystrophy
- •11.1.1.1 Clinical Features: STGD
- •11.1.1.2 Diagnostic Features: STGD
- •11.1.1.3 Differential Diagnosis: STGD
- •11.1.1.4 Inherited Forms: STGD
- •11.1.2 Best Macular Dystrophy
- •11.1.2.1 Clinical Features: BMD
- •11.1.2.2 Diagnostic Features: BMD
- •11.1.2.3 Differential Diagnosis: BMD
- •11.1.2.4 Inherited Forms: BMD
- •11.1.3 Juvenile X-Linked Retinoschisis
- •11.1.3.1 Clinical Features: JXRS
- •11.1.3.2 Diagnostic Features: JXRS
- •11.1.3.3 Differential Diagnosis: JXRS
- •11.1.3.4 Inherited Forms: JXRS
- •11.2.2 Molecular Genetic Testing
- •11.2.3.1 ABCR
- •11.2.3.2 ELOVL4
- •11.2.3.3 PROM1
- •11.2.3.4 BEST-1
- •11.3.1 STGD
- •11.3.3 JXRS
- •11.4.1 STGD Models
- •11.4.2 BMD Models
- •11.4.3 JXRS Models
- •11.5 Phenotypic Diversity
- •11.6 Potential Therapeutics for Juvenile Macular Degenerations
- •References
- •12: Generalized Inherited Retinal Dystrophies
- •12.1 Introduction
- •12.2 Historical Context
- •12.4.1 Retinitis Pigmentosa
- •12.4.1.1 Overview with Clinical Significance
- •12.4.1.2 Genetics
- •12.4.1.3 Pathophysiology
- •12.4.1.4 Prevalence
- •12.4.1.5 Patient History and Evaluation
- •12.4.1.6 Diagnostic Testing
- •12.4.1.7 Treatment
- •12.4.2 Congenital Leber Amaurosis
- •12.4.2.1 Genetics
- •12.4.2.2 Pathophysiology
- •12.4.2.3 Incidence/Prevalence
- •12.4.2.4 Natural History and Prognosis
- •12.4.2.5 Diagnostic Testing
- •12.4.2.6 Treatment
- •12.4.3.1 Genetics
- •12.4.3.2 Pathophysiology
- •12.4.3.3 Incidence
- •12.4.3.4 Natural History and Prognosis
- •12.4.3.5 Diagnostic Testing
- •12.4.3.6 Treatment
- •12.4.3.7 Achromatopsia
- •12.4.4.1 Genetics
- •12.4.4.2 Pathophysiology
- •12.4.4.3 Incidence
- •12.4.4.4 Evaluation and Prognosis
- •12.4.4.5 Diagnostic Testing
- •12.4.4.6 Treatment
- •12.4.4.7 Complications and Disease Associations
- •12.4.4.8 Social Considerations
- •References
- •13: Vitreoretinal Dystrophies
- •13.1 Stickler Syndrome
- •13.1.1 Introduction
- •13.1.2 Historical Context
- •13.1.3 Overview with Clinical Significance
- •13.1.4 Classification
- •13.1.5 Genetics
- •13.1.6 Pathophysiology
- •13.1.7 Incidence
- •13.1.8 Natural History and Prognosis of STK (Signs, Symptoms, Timing, etc.)
- •13.1.9 Diagnosis and Diagnostic Aids
- •13.1.10 Treatment
- •13.1.11 Complications and Associations
- •13.1.12 Social and Family Impact
- •13.2 Wagner Disease
- •13.2.1 Introduction
- •13.2.2 Historical Context
- •13.2.3 Overview with Clinical Significance
- •13.2.4 Classification
- •13.2.5 Genetics
- •13.2.6 Pathophysiology
- •13.2.7 Incidence
- •13.2.9 Diagnosis and Diagnostic Aids
- •13.2.10 Treatment
- •13.2.11 Complications and Associations
- •13.2.12 Social and Family Impact
- •13.3 Juvenile X-Linked Retinoschisis
- •13.3.1 Introduction
- •13.3.2 Historical Context
- •13.3.3 Overview with Clinical Significance
- •13.3.4 Classification
- •13.3.5 Genetics
- •13.3.6 Pathophysiology
- •13.3.7 Incidence
- •13.3.9 Diagnosis and Diagnostic Aids
- •13.3.10 Treatment
- •13.3.11 Complications and Associations
- •13.3.12 Social and Family Impact
- •13.4.1 Introduction
- •13.4.2 Historical Context
- •13.4.3 Overview with Clinical Significance
- •13.4.4 Classification
- •13.4.5 Genetics
- •13.4.6 Pathophysiology
- •13.4.7 Incidence
- •13.4.9 Diagnosis and Diagnostic Aids
- •13.4.10 Treatment
- •13.4.11 Complications and Associations
- •13.4.12 Social and Family Impact
- •13.5 Goldmann-Favre Syndrome
- •13.5.1 Introduction
- •13.5.2 Historical Context
- •13.5.3 Overview with Clinical Significance
- •13.5.4 Classification
- •13.5.5 Genetics
- •13.5.6 Pathophysiology
- •13.5.7 Incidence
- •13.5.9 Diagnosis and Diagnostic Aids
- •13.5.10 Treatment
- •13.5.11 Complications and Associations
- •13.5.12 Social and Family Impact
- •13.6 Incontinentia Pigmenti (IP)
- •13.6.1 Introduction
- •13.6.2 Historical Context
- •13.6.3 Overview with Clinical Significance
- •13.6.4 Classification
- •13.6.5 Genetics
- •13.6.6 Pathophysiology
- •13.6.7 Incidence
- •13.6.9 Diagnosis and Diagnostic Aids
- •13.6.10 Treatment
- •13.6.11 Complications and Associations
- •13.6.12 Social and Family Impact
- •13.7.9 Diagnosis and Diagnostic Aids
- •13.7.10 Treatment
- •13.7.11 Complications and Associations
- •13.7.12 Social and Family Impact
- •References
- •14.1 Introduction
- •14.2 Clinical Course
- •14.3 Differential Diagnosis
- •14.4 Pathology
- •14.5 Selected Conditions
- •14.6 Treatment
- •References
- •15: Proliferative Retinopathies in Children
- •15.1 Introduction
- •15.2 Historical Context
- •15.3 Overview with Clinical Significance
- •15.4 Classification
- •15.5 Genetics (table 15.1)
- •15.5.1 Pathophysiology
- •15.5.2 Natural History and Prognosis
- •15.5.3 Diabetes Mellitus
- •15.5.4 Sickle Cell Disease
- •15.5.5 Incontinentia Pigmenti
- •15.6 Complications and Associations
- •15.7 Social and Family Impact
- •References
- •16: Infectious Diseases of the Pediatric Retina
- •16.1 Introduction
- •16.2 Protozoal Diseases
- •16.2.1 Toxoplasma gondii
- •16.2.1.1 Life Cycle and Transmission
- •16.2.1.2 Epidemiology
- •16.2.1.3 Congenital Infection
- •16.2.1.4 Ocular Disease
- •16.2.1.5 Immunocompromised Patients
- •16.2.1.6 Diagnosis of Ocular Toxoplasmosis
- •16.2.1.7 Treatment
- •16.2.1.8 Treatment in Special Situations
- •16.3 Viral Diseases
- •16.3.1 Cytomegalovirus Retinitis
- •16.3.1.1 Congenital CMV Infection
- •16.3.1.2 Ocular Manifestations
- •16.3.1.3 Acquired CMV Infection
- •16.3.1.4 Ocular Disease
- •16.3.1.5 Pathology
- •16.3.1.6 Diagnosis
- •16.3.1.7 Therapy
- •16.3.2 Varicella Zoster Virus
- •16.3.2.1 Ocular Manifestations
- •16.3.3 Herpes Simplex Virus
- •16.3.3.1 Ocular Disease
- •16.3.4 Acute Retinal Necrosis
- •16.3.4.1 Clinical Presentation
- •16.3.4.2 Diagnosis
- •16.3.4.3 Treatment
- •16.3.5 HIV Infection
- •16.3.5.1 Ocular Manifestations
- •16.3.5.2 Noninfectious HIV Microangiopathy
- •16.3.6 Measles
- •16.3.7 Rubella
- •16.3.7.1 Congenital Rubella Syndrome
- •16.4 Parasitic Infection
- •16.4.1 Toxocariasis
- •16.4.1.1 Ocular Involvement
- •16.4.1.2 Diagnosis
- •16.4.1.3 Differential Diagnosis
- •16.4.1.4 Treatment
- •16.4.2 Onchocerciasis
- •16.4.2.1 Ocular Manifestations
- •16.4.2.2 Diagnosis and Treatment
- •16.5 Bacterial Diseases
- •16.5.1 Syphilis
- •16.5.1.1 Clinical Manifestations
- •16.5.1.2 Congenital Syphilis
- •16.5.1.3 Acquired Syphilis
- •16.5.1.4 Diagnosis
- •16.5.1.5 Syphilis and AIDS
- •16.5.1.6 Treatment
- •16.5.2 Tuberculosis
- •16.5.2.1 Ocular Manifestation
- •16.5.2.2 Diagnosis
- •16.5.2.3 Tuberculosis and AIDS
- •16.5.2.4 Treatment
- •16.6 Rare Childhood Bacterial Diseases
- •16.6.1 Brucellosis
- •16.6.2 Leptospirosis
- •16.6.3 Lyme Disease
- •16.6.4 Cat Scratch Disease
- •16.7 Fungal Disease
- •16.7.1 Histoplasmosis
- •16.7.1.1 Ocular Histoplasmosis Syndrome (OHS)
- •16.7.1.2 Diagnosis and Treatment
- •16.7.2 Fungal Endophthalmitis
- •16.7.2.1 Endogenous Fungal Endophthalmitis
- •Candidiasis
- •Ocular Features
- •Diagnosis and Treatment
- •Rare Causes of Endogenous Endophthalmitis
- •Aspergillosis
- •Cryptococcosis
- •Histoplasmosis
- •Pneumocystis carinii
- •North American Blastomycosis
- •Coccidiomycosis
- •Other Fungal Infections
- •16.7.2.2 Exogenous Fungal Endophthalmitis
- •16.8 Rickettsial Disease
- •References
- •17.1 Introduction
- •17.2 Age of Victims
- •17.4 Perpetrators
- •17.5 Brain Injury
- •17.6 Skeletal Injuries
- •17.7 Acute Ophthalmic Findings
- •17.8 Dating of Retinal Hemorrhages
- •17.9 Treatment of Retinal Hemorrhages
- •17.10 Late Ophthalmic Findings
- •17.13 The Role of the Ophthalmologist
- •References
- •18: Pediatric Retinal Trauma
- •18.1 Introduction
- •18.2 Epidemiology
- •18.3 Etiology of Trauma
- •18.3.1 Sports
- •18.3.2 Assault
- •18.3.3 Birth Trauma
- •18.3.4 Projectile Injury
- •18.3.5 Miscellaneous Causes
- •18.3.6 Sympathetic Ophthalmia
- •18.4 Closed Globe Injuries
- •18.4.1 Traumatic Macular Hole
- •18.4.2 Commotio Retinae
- •References
- •19: Pediatric Uveitis
- •19.1 General Introduction
- •19.2 Classification
- •19.3 Social and Family Impact
- •19.4 Noninfectious
- •19.4.1 Juvenile Rheumatoid Arthritis
- •19.4.1.1 Historical Context
- •19.4.1.2 Clinical Findings/Natural History
- •Subtypes of JRA (Table 19.2) .
- •Screening Guidelines
- •Pathophysiology
- •Diagnosis/Treatment
- •Genetics
- •Complications
- •19.4.2 HLA-B27-Associated Uveitis
- •19.4.2.1 Historical Context
- •19.4.2.2 Clinical Findings/Natural History
- •Pathophysiology/Genetics
- •Diagnosis/Treatment/Complications
- •19.4.3 Tub ulointerstitial Nephritis and Uveitis (TINU)
- •19.4.3.1 Historical Context
- •19.4.3.2 Clinical Findings/Natural History
- •Pathophysiology/Genetics
- •Diagnosis/Treatment/Complications
- •19.4.4 Sarcoidosis
- •19.4.4.1 Historical Context
- •19.4.4.2 Clinical Findings/Natural History
- •Pathophysiology
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.4.5 Pars Planitis
- •19.4.5.1 Historical Context
- •19.4.5.2 Clinical Findings/Natural History
- •Pathophysiology/Genetics
- •Diagnosis
- •Treatment
- •Step 1
- •Step 2
- •Step 3
- •Step 4
- •Complications
- •19.5 Infectious
- •19.5.1 Toxoplasmosis
- •19.5.1.1 Historical Context/Pathophysiology
- •19.5.1.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.2 Toxocariasis
- •19.5.2.1 Historical Context/Pathophysiology
- •19.5.2.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.3 Bartonella henselae
- •19.5.3.1 Historical Context/Pathophysiology
- •19.5.3.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.4.1 Historical Context/Pathophysiology
- •19.5.4.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •19.5.5 Congenital Ocular Syphilis
- •19.5.5.1 Historical Context/Pathophysiology
- •19.5.5.2 Clinical Findings/Natural History
- •Genetics
- •Diagnosis/Treatment/Complications
- •References
- •Index
17 Abusive Head Trauma/Shaken Baby Syndrome |
419 |
|
|
17.13 The Role of the Ophthalmologist
Physicians are rarely in the position to make a diagnosis with such profound significance to patients and their families. Ascertainment of child abuse is critical to prevent potentially fatal recurrence in victims. Extensive intraocular hemorrhage in young infants in the setting of acute brain injury, and in the absence of a history of severe accidental trauma or underlying medical cause, must be considered to be nonaccidental injury until otherwise proven.
If AHT is suspected, examination of the eye through undilated pupils with a direct ophthalmoscope is inadequate for complete evaluation. Indirect ophthalmoscopy with pharmacologic dilation of the pupils (unless contraindicated from a neurologic standpoint, or if the pupils are fixed and dilated as a result of severely compromised neurological status) is an essential aspect of diagnosis, The primary role of the ophthalmologist in the care of these children is to provide a complete evaluation of the ocular injuries including proper detailed documentation of the eye findings, along with retinal photography when available. The written consultation should reflect the current state of the medical literature: if the child has severe multilayered retinal hemorrhages, too numerous to count, and extending to the retinal periphery with no obvious explanatory cause, then the diagnosis is AHT until proven otherwise. If there is a nonspecific mild hemorrhagic retinopathy with a just a few posterior pole intraretinal hemorrhages, then AHT should be mentioned in the differential diagnosis (it is the most common cause of retinal hemorrhage in young children after birth hemorrhage) with suggestions for other causative entities to be considered.
The eye examination may also provide prognostic information. Ophthalmologists should coordinate longterm management of the frequent visual complications. In cases of a fatal outcome, the ophthalmologist can help direct the pathologist’s postmortem examination by suggesting the desired evaluation of the eyes, orbital tissues, and optic nerves as discussed above.
Ophthalmologists, and for that matter all physicians, are not responsible for determining who perpetrated the act of abuse. It may be that the perpetrator is a parent who is present during the eye care of the child. The ophthalmologist must continue to act in the same professional manner with these caretakers as they would with any parent. Remember that the overwhelming majority of perpetrators did not purposely set out
to injure the child, but rather lost control in rage often responsive to the stresses of life, a crying baby, or other frustrations of child rearing. There is a remarkable parallel between the normal crying curve of infancy and the incidence of AHT [93]. When the ophthalmologist is called to court as an expert witness (an uncommon occurrence), the testimony should be kept within the ophthalmologist’s comfort level for knowledge on this subject, impartial to the side for which they were asked to testify, and restricted to the medical evidence rather than feelings about whom the perpetrator might be.
Physicians who treat infants and children are mandated to report suspected child abuse to child welfare agencies for investigation, and ophthalmologists who encounter children with ophthalmic manifestations of abuse need to ensure that proper steps are taken to protect their patients from further harm. Ophthalmologists should work as a part of the multidisciplinary team that collaborates in unison to identify cases of abuse and ensure optimum diagnostic accuracy.
References
1. Guthkelch, A.: Serious side effects of shaking were described in 1971. Br. Med. J. 310, 1600 (1995)
2. Caffey, J.: The whiplash shaken infant syndrome: Manual shaking by the extremities with whiplash-induced intracranial and intraocular bleedings, linked with residual permanent brain damage and mental retardation. Pediatrics 54, 396–403 (1974)
3. Duhaime, A., Gennarelli, T.A., Thibault, L.E.: The shaken baby syndrome: a clinical, pathological, and biomechanical study. J. Neurosurg. 66, 409–415 (1987)
4. Cory, C.Z.: Can shaking alone cause fatal brain injury? A biomechanical assessment of the Duhaime Shaken Baby syndrome model. Med. Sci. Law 43(4), 317–333 (2003)
5. Reece, R., Nicholson, CE. (eds.): Inflicted Childhood Neurotrauma. American Academy of Pediatrics, Chicago (2003)
6. Starling, S., Holden, J., Jenny, C.: Abusive head trauma: the relationship of perpetrators to their victims. Pediatrics 95, 259–262 (1995)
7. Brenner, R.A., Overpeck, M.D., Trumble, A.C., DerSimonian, R., Berendes, H.: Deaths attributable to injuries in infants, United States, 1983-1991. Pediatrics 103, 968–974 (1999)
8. Overpeck,R.A.,Brenner,A.C.,Trumble,L.B.,Trifilette,L.B., Berendes, H.W.: Risk factors for infant homicide in the US. N. Engl. J. Med. 339, 1211–1216 (1998)
9. Lazoritz, S., Baldwin, S., Kini, N.: The whiplash shaken infant
syndrome: has Caffey’s syndrome changed or have we changed his syndrome? Child Abuse Negl. 21, 1009–1014 (1997)
10.Merten, D.F., Osborne, D.R.S., Radkowski, M.A., et al.: Craniocerebral trauma in the child abuse syndrome: radiological observations. Pediatr. Radiol. 14, 272–277 (1984)
420 |
B.J. Forbes and A.V. Levin |
|
|
11.Brown, J., Minns, R.: Non-accidental head injury, with particular reference to whiplash shaking injury and medico legal aspects. Dev. Med. Child Neurol. 35, 849–869 (1993)
12.Levin, A.: Ocular manifestations of child abuse. Ophthalmol. Clin. North. Am. 3, 249–264 (1990)
13.Harcourt, B., Hopkins, D.: Ophthalmic manifestations of the battered-baby syndrome. Br. Med. J. 3, 398–401 (1971)
14.Morad, Y., Kim, Y.M., Armstrong, D.C., Huyer, D., Mian, M., Levin, A.V.: Correlation between retinal abnormalities and intracranial abnormalities in the Shaken Baby syndrome. Am.
J.Ophthalmol. 134, 354–359 (2002)
15.Rao, N., Smith, R.E., Choi, J.H., et al.: Autopsy findings in the eyes of fourteen fatally abused children. Forensic Sci. Int. 39, 293–299 (1988)
16.Green, M.A., Lieberman, G., Milroy, C.M., Parsons, M.A.: Ocular and cerebral trauma in non-accidental injury in infancy: underlying mechanisms and implications for paediatric practice. Br. J. Ophthalmol. 80, 282–287 (1996)
17.Altman, R.L., Kutscher, M.O., Brand, D.A.: The “Shaken baby syndrome”. N. Engl. J. Med. 339, 1329–1330 (1998)
18.Duhaime,A.C.,Christian,C.W.,Rorke,L B.,Zimmerman,R.A.: Nonaccidental head injury in infants – the “shaken baby syndrome”. N. Engl. J. Med. 338, 1822–1829 (1998)
19.Kivlin, J.D., Simons, K.B., Lazoritz, A., Ruttum, M.S.: Shaken baby syndrome. Ophthalmology 107, 1246–1254 (2000)
20.Lancon, J., Haines, D., Parent, A.: Anatomy of the shaken baby syndrome. Anat. Rec. 253, 13–18 (1998)
21.Rivera, F.: Population-based study of fall injuries in children and adolescents resulting in hospitalization or death. Pediatrics 92, 61–63 (1993)
22.Jenny, C., Hymel, K.P., Ritzen, A., et al.: Analysis of missed cases of abusive head trauma. JAMA 281, 621–626 (1999)
23.Lane, W.G., Rubin, D.M., Monteith, R., Christian, C.W.: Racial differences in the evaluation of pediatric fractures for physical abuse. JAMA 288, 1603–1609 (2002)
24.Bonnier, C., Nassonge, M., Errard, P.: Outcome and prognosis of whiplash shaken infant syndrome; late consequences after a symptom-free interval. Dev. Med. Child Neurol. 37, 943–956 (1995)
25.Ewing-Cobbs, L., et al.: Neuroimaging, physical and developmental findings after inflicted and noninflicted traumatic brain injury in young children. Pediatrics 102, 300–307 (1998)
26.Altman, R.L., Kutscher, M.L., Brand, D.A.: The “shaken baby syndrome” [letter]. N. Engl. J. Med. 339, 1329–1330 (1988)
27.Pitetti, R.D., Maffei, F., Chang, K., Hickey, R., Berger, R., Pierce, M.C.: Prevalence of retinal hemorrhages and child abuse in children who present with an apparent life-threaten- ing event. Pediatrics 110, 557–562 (2002)
28.Barlow, B., Niermirska, M., Gandhi, R.P., LeBlanc, W.: Ten years of experience with falls from a height in children.
J.Pediatr. Surg. 18(4), 509–511 (1983)
29.Kravitz, H., Driessen, G., Gomberg, R., Korach, A.: Accidental falls from elevated surfaces in infants from birth to one year of age. Pediatrics 44(5), 869–876 (1969)
30.Plunkett, J.: Fatal pediatric head injuries caused by short distance falls. Am. J. Forensic Med. Pathol. 22, 1–12 (2001)
31.Chadwick, D., Bertocci, G., Castillo, E., et al.: The annual risk of death from short falls of young children: less than one in a million. Pediatrics 121(6), 1213–1224 (2008)
32.Swenson, J., Levitt, C.: Shaken baby syndrome: diagnosis and prevention. Minn. Med. 80, 41–44 (1997)
33.Duhaime, A., et al.: Long-term outcome in infants with the shak- ing-impact syndrome. Pediatr. Neurosurg. 24, 292–298 (1996)
34.Pounder, D.: Shaken adult syndrome. Am. J. Forensic Med. Pathol. 6, 154–157 (1995)
35.DiScala, C., Sege, R., Li, G., Reece, R.M.: Child abuse and unintentional injuries. A ten-year retrospective. Arch. Pediatr. Adolesc. Med. 154, 16–22 (2000)
36.Kraus, J., Rock, A., Hemyari, M.: Brain injuries among infants, children, adolescents, and young adults. Am. J. Dis. Child 144, 684–691 (1990)
37.Fischer, H., Allasio, D.: Permanently damaged: long-term follow-up of shaken babies. Clin. Pediatr. 33, 696–698 (1994)
38.Nashelsky, M., Dix, J.: The time interval between lethal infant shaking and the onset of symptoms: a review of the shaken baby syndrome literature. Am. J. Forensic Med. Pathol. 6, 154–157 (1995)
39.Ewing-Cobbs, L., Kramer, L., Prasad, M., et al.: Neuroimaging, physical, and developmental findings after inflicted and noninflicted traumatic brain injury in young children. Pediatrics 102, 300–307 (1998)
40.Ellis, M.: The pathology of fatal child abuse. Pathology 29, 113–121 (1997)
41.Feldman, K.W., Bethel, R., Shugerman, R.P., et al.: The cause of infant and toddler subdural hemorrhage: a prospective study. Pediatrics 108, 636–646 (2001)
42.Gayle, M.O., Kisson, N., Gerd, R.W., et al.: Retinal hemorrhage in the young child: a review of etiology, predisposed conditions, and clinical implications. J. Emerg. Med. 13, 233–239 (1995)
43.Child Abuse Prevention Center.: Research project on the incidence and risk factors of shaken baby syndrome in the State of Utah, pp. 1–18. Child Abuse Prevention Center, Ogden, Utah (1998)
44.Merten, D.F., Osborne, D.R.S., Radkowski, M.A., Leonidas, J.O.: Craniocerebral trauma in the child abuse syndrome: radiological observations. Pediatr. Radiol. 14, 272–277 (1984)
45.Pierre-Kahn, V., Roche, O., Dureau, P.: Ophthalmologic findings in suspected child abuse victims with subdural hematomas. Ophthalmology 110, 1718–1723 (2003)
46.Morad, Y., Avni, I., Capra, L., Case, M.E., Feldman, K., Kodsi, S.R., Esernio-Jenssen, D., Lukefar, J., Levin, A.: Shaken Baby syndrome without intracranial hemorrhage on initial computed tomography. JAAPOS 8(6), 521–526 (2004)
47.Morad, Y., Avni, I., Benton, S.A., Berger, R., Byerley, J.S., Coffman, K., Greeley, C.S., Gustavson, E.E., Lenane, A., Levitt, C.J., Topley, J., Levin, A.V.: Normal computerized tomography of brain in children with Shaken Baby syndrome. JAAPOS 8(5), 445–450 (2004)
48.Gilliland, M., Luckenbach, M., Chenier, T.: Systemic and ocular findings in 169 prospectively studied child deaths: retinal hemorrhages usually mean child abuse. Forensic Sci. Int. 68, 117–132 (1994)
49.Mills, M.D.: Association of funduscopic lesions with fatal outcome in Shaken Baby syndrome. JAAPOS 2, 67–71 (1998)
50.Sturm, V., Landau, K., Menke, M.N.: Optical coherence tomography findings in Shaken Baby syndrome. Am. J. Ophthalmol. 146, 363–368 (2008)
51.Gaynon, M., Koh, K., Marmor, M., Frankel, L.R.: Retinal folds in the shaken baby syndrome. Am. J. Ophthalmol. 106, 423–425 (1988)
17 Abusive Head Trauma/Shaken Baby Syndrome |
421 |
|
|
52.Lantz, P.E., Sinal, S.H., Stanton, C.A., Weaver Jr., R.G.: Perimacular retinal folds from childhood head trauma. Br. Med. J. 328(7442), 754–756 (2004)
53.Lueder, G.T., Turner, J.W., Paschall, R.: Perimacular retinal folds simulating nonaccidental injury in an infant. Arch. Ophthalmol. 124(12), 1782–1783 (2006)
54.Gnanaraj, L., Gilliland, M.G.F., Yahya, R.R., Rutka, J.T., Drake, J., Dirks, P., Levin, A.V.: Ocular manifestations of crush head injury in children. Eye 21, 5–10 (2007)
55.Gleckman, A.: Optic nerve damage in shaken baby syndrome: detection by for betaamyloid precursor protein immunohistochemistry. Arch. Pathol. Lab. Med. 124, 251–256 (2000)
56.Budenz, D.L., Farber, M.G., Mirchandani, H.G., Park, H., Rorke, L.B.: Ocular and optic nerve hemorrhages in abused infants with intracranial injuries. Ophthalmology 101(3), 559–565 (1994)
57.Gilliland, M.G., Levin, A.V., Enzenauer, R.W., Smith, C., Parsons, M.A., Rorke-Adams, L.B., Lauridson, J.R., La Roche, G.R., Christmann, L.M., Mian, M., Jentzen, J., Simons, K., Morad, Y., Alexander, R., Jenny, C., WygnanskiJaffe, T.: Guidelines for postmortem protocol for ocular investigation of sudden unexplained infant death and suspected physical child abuse. Am. J. Forensic Med. Pathol. 28(4), 323–329 (2007)
58.Adams, G.G., Clark, B.J., Fang, S., Hill, M.: Retinal haemorrhages in an infant following RetCam screening for retinopathy of prematurity. Eye 18(6), 652–653 (2004)
59.Lim, Z.: Najm Tehrani N, Levin AV: Retinal hemorrhages in a preterm infant following screening examination for retinopathy of prematurity. Br. J. Ophthalmol. 90, 799–800 (2006)
60.Haviland, J., Russell, R.I.: Outcomes after severe non-acci- dental head injury. Arch. Dis. Child 77, 504–507 (1997)
61.Matthews, G.P., Das, A.: Dense vitreous hemorrhages predict poor visual and neurological prognosis in infants with shaken baby syndrome. J. Pediatr. Ophthalmol. Strabismus 33, 260–265 (1996)
62.McCabe, C.F., Donahue, S.P.: Prognostic indicators for vision and mortality in shaken baby syndrome. Arch. Ophthalmol. 118, 373–377 (2000)
63.Wilkenson, W.S., Han, D.P., Rappley, M.D., Owings, C.L.: Retinal hemorrhage predicts neurologic injury in the shaken baby syndrome. Arch. Ophthalmol. 107, 1472–1474 (1989)
64.Duhaime, A.C., Alario, A.J., Lewander, W.J., Schut, L., et al.: Head injury in very young children: mechanisms, injury types and ophthalmic findings in 100 hospitalized patients younger than 2 years of age. Pediatrics 90, 179–185 (1992)
65.Gilles, E., McGregor, M.L., Levy-Clarke, G.: Retinal hemorrhage asymmetry in inflicted head injury: A clue to pathogenesis. J. Pediatr. 143, 494–499 (2003)
66.Han, D.P., Wilkinson, W.S.: Late ophthalmic manifestations of the shaken baby syndrome. J. Pediatr. Ophthalmol. Strabismus 27, 300–302 (1990)
67.Duane, T., Osher, R., Green, W.: White centered hemorrhages: their significance. Ophthalmology 87(1), 66–69 (1980)
68.Emerson, M.V., Pieramici, D.J., Stoessel, K.M., Berreen, J.P., Gariano, R.F.: Incidence and rate of disappearance of retinal hemorrhage in newborns. Ophthalmology 108(1), 36–39 (2001)
69.Kaur, B., Taylor, D.: Fundus hemorrhages in infancy. Surv. Ophthalmol. 37, 1–17 (1992)
70.Buys, Y.M., Levin, A.V., Enzenauer, R.W., Elder, J.E., et al.: Retinal findings after head trauma in infants and young children. Ophthalmology 99, 1718–1723 (1992)
71.Christian, C.W., Taylor, A.A., Hertle, R.W., Duhaime, A.C.: Retinal hemorrhages caused by accidental household trauma. J. Pediatr. 135, 125–127 (1999)
72.Kivlin, J.D., Currie, M.L., Greenbaum, V.J., Simons, K.B., Jentzen, J.: Retinal hemorrhages in children following fatal motor vehicle crashes. Arch. Ophthalmol. 126(6), 800–804 (2008)
73.Forstner, R., Hoffman, G.F., Gassner, I.: Glutaric aciduria type 1: ultrasonic demonstration of early signs. Pediatr. Radiol. 29, 138–143 (1999)
74.Goetting, M.G., Sowa, B.: Retinal hemorrhage after cardiopulmonary resuscitation in children: an etiologic reevaluation. Pediatrics 85, 585–588 (1990)
75.Kramer, K., Goldstein, B.: Retinal hemorrhages following cardiopulmonary resuscitation. Clin. Pediatr. 32, 366–368 (1993)
76.Gilliland, M.G.F., Luckenbach, M.W.: Are retinal hemorrhages found after resuscitation attempts? A study of the eyes of 169 children. Am. J. Forensic Med. Pathol. 14, 187– 192 (1993)
77.Odom, A., Christ, E., Kerr, N., et al.: Prevalence of retinal hemorrhages in pediatric patients after in-hospital cardiopulmonary resuscitation: a prospective study. Pediatrics 99, E3 (1997)
78.Marr, W., Marr, E.: Some observations on Purtscher’s disease: traumatic retinal aniopathy. Am. J. Ophthalmol. 54, 693–705 (1962)
79.Mills, M.: Terson syndrome. Ophthalmology 105(12), 2161–2162 (1998)
80.Arlotti, S.A., Forbes, B.J., Diaz, M.S., Bonsall, D.J.: Unilateral retinal hemorrhages in shaken baby syndrome. JAAPOS 11(2), 175–178 (2007)
81.American Academy of Pediatrics Committee on Child Abuse and Neglect: Distinguishing sudden infant death syndrome from child abuse fatalities. Pediatrics 94, 124–126 (1994)
82.Fahmy, J.: Fundal haemorrhages in ruptured intracranial aneurysms. Material, frequency and morphology. Acta Ophthamol. 51, 289–298 (1973)
83.Timberlake, W., Kubik, C.: Follow-up report with clinical and anatomical notes on 280 patients with subarachnoid hemorrhage. Trans. Am. Neurol. Assoc. 77, 26–30 (1952)
84.Scheibner, V.: Shaken baby syndrome: the vaccination link. Nexus 87, 35–38 (1998)
85.Friedlander, E.: Opposition to immunization: a pattern of deception. Sci. Rev. Altern. Med. 5(1), 18–23 (2001)
86.Chiu, C., Chuang, Y., Su, L.: Subconjunctival hemorrhage and respiratory distress. Lancet 358, 724 (2001)
87.Geddes, J.F., Plunkett, J.: The evidence base for shaken baby syndrome. Br. Med J 328(7442), 719–720 (2004)
88.Smith, R., Smith, W.: Arachnoid cysts of the middle cranial fossa. Surg. Neurol. 5, 246–252 (1976)
89.Allison, J.W., Davis, P.C., Sato, Y.: Intracranial aneuryms in childhood and adolescence. J. Neurosurg. 70, 420–425 (1989)
90.Green, M.: Ocular and cerebral trauma in non-accidental injury in infancy: underlying mechanism and implications for pediatric practice. Br. J. Ophthalmol. 80, 282–287 (1996)
422 |
B.J. Forbes and A.V. Levin |
|
|
91.Levin, A.V.: The retinal hemorrhages of crush head injury: learning from outliers. Arch. Ophthalmol. 124(12), 1773– 1774 (2006)
92.Levin, A.V.: Retinal haemorrhages and child abuse. In: David, T.J. (ed.) Recent Advances in Paediatrics, no. 18. Churchill Livingstone, London, pp. 151–219 (2000)
93.Barr, R.G., Trent, R.B.: Age related incidence curve of hospitalized Shaken Baby syndrome cases: convergent evidence for crying as a trigger to shaking. Child Abuse Negl. 30(1), 7–17 (2006)
